Virus News and Research

Latest Virus News and Research

Antifungal agent Bifonazole as an antiviral against SARS-CoV-2

In a recent study published in the journal Molecular Therapy, researchers identified Bifonazole, an imidazole-based antifungal agent, to have potent activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using high-throughput screening of small molecules.

12 May 2022

The promise of RNA medicine is targeted and personalized

The development of messenger RNA (mRNA) vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has only increased the impetus in this field.

11 May 2022

MRC/UVRI and LSHTM Uganda Research Unit launches new state-of-the-art clinical research facility

The MRC/UVRI and LSHTM Uganda Research Unit has unveiled a new state-of-the-art clinical research facility in Entebbe to further boost its contributions to science, policy and practice in Uganda.

11 May 2022

Inexpensive daily diet supplementation in pregnancy can reduce complications at birth, study shows

A six-year study of nearly 100,000 women in Botswana has provided new evidence that relatively inexpensive daily diet supplementation of iron, folic acid and vitamin supplementation in pregnancy can reduce complications at birth.

11 May 2022

Discovery of host co-factors necessary for SARS-CoV2 infection

A new study published in the journal EMBO Reports has reported on the shedding of two proteases, namely, ADAM10 and ADAM17, which aids in S protein-dependent molecular events.

11 May 2022

UC Davis researchers identify a protein that keeps Kaposi's sarcoma-associated herpesvirus dormant

A team of UC Davis researchers has identified a protein in the cancer cell's nucleus as a critical agent keeping Kaposi's sarcoma-associated herpesvirus (KSHV) dormant and undetected by the body's immune system.

11 May 2022

Direct influenza infection of the heart drives cardiac complications, study reveals

Researchers have shown for the first time in mice that heart problems associated with the flu are not caused by raging inflammation in the lungs, as has long been predicted.

11 May 2022

First oral antiviral approved for early treatment of COVID-19

The United States Food and Drug Administration granted an Emergency Use Authorization in December 2021 for the first oral antiviral, a pill containing two protease inhibitors – nirmatrelvir and ritonavir (Paxlovid, Pfizer) – for early treatment of COVID-19.

11 May 2022

Study shows efficacy of COVID-19 vaccine in people receiving cancer treatment

People undergoing active cancer treatment, including stem cell transplant, should receive the COVID-19 vaccine, according to a study published in JAMA Oncology.

11 May 2022

Unique binding property may explain the ability of delta variant to spread more rapidly

Unlike other SARS-CoV-2 variants, the Delta variant can attach to copies of itself, forming larger aggregations, or clumps, of viral particles, suggests a study by scientists at the National Institutes of Health.

11 May 2022

Review portrays clinical journey of messenger RNA vaccines and mRNA-based therapies

Researchers reviewed messenger ribonucleic acid (mRNA) technology and highlighted its clinical applications.

11 May 2022

COVID-19-induced non-cell-autonomous anosmia

Researchers reported that SARS-CoV-2-induced anosmia was based on non-cell-independent processes.

11 May 2022

Study investigates antibody-mediated response against different SARS-CoV-2 variants

In a recent study posted to the bioRxiv* preprint server, researchers assessed the impact of coronavirus disease 2019 (COVID-19) on antibody-mediated immunity.

10 May 2022

Decoy ACE2 nanoparticles block the entry of SARS-CoV-2 into cells

In a recent study posted to the bioRxiv* preprint server, researchers reported that nanoparticles could prevent severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) cell entry.

10 May 2022

COVID-19 severity has a stronger influence on prevention practices, study shows

It is daunting to think that there could be another pandemic in this lifetime. Understanding and documenting behavioral aspects during the COVID-19 pandemic will help to better prepare society for the next one.

10 May 2022

UCLouvain discovery could counter SARS-CoV-2 virus independently of the mutations

Despite the effectiveness of vaccination campaigns worldwide, the threat posed by Covid-19 still exists. First of all, a new SARS-CoV-2 variant could very well emerge that may not respond to current vaccines.

10 May 2022

Researchers warn against national strategies for a "new normal" of life with COVID-19

Researchers are warning U.S. leaders and health officials against national strategies for a "new normal" of life with COVID-19.

10 May 2022

Narcissism affects an individual's willingness to comply with COVID-19 mitigations

Throughout the COVID-19 pandemic, experts have encouraged mitigation strategies like masking and vaccination to help reduce the spread of the virus.

10 May 2022

Postnatal gene therapy may be able to prevent or reverse deadly effects of Pitt-Hopkins syndrome

UNC School of Medicine Scientists have shown for the first time that postnatal gene therapy may be able to prevent or reverse many deleterious effects of a rare genetic disorder called Pitt-Hopkins syndrome.

10 May 2022

Exploring simultaneous and sequential COVID-19 vaccine candidate

Researchers developed novel lipid nanoparticle (LNP)-based messenger ribonucleic acid vaccine formulations against three pathogenic coronaviruses.

10 May 2022

Virus News and Research

Latest Virus News and Research

Antifungal agent Bifonazole as an antiviral against SARS-CoV-2

The promise of RNA medicine is targeted and personalized

MRC/UVRI and LSHTM Uganda Research Unit launches new state-of-the-art clinical research facility

Inexpensive daily diet supplementation in pregnancy can reduce complications at birth, study shows

Discovery of host co-factors necessary for SARS-CoV2 infection

UC Davis researchers identify a protein that keeps Kaposi's sarcoma-associated herpesvirus dormant

Direct influenza infection of the heart drives cardiac complications, study reveals

First oral antiviral approved for early treatment of COVID-19

Study shows efficacy of COVID-19 vaccine in people receiving cancer treatment

Unique binding property may explain the ability of delta variant to spread more rapidly

Review portrays clinical journey of messenger RNA vaccines and mRNA-based therapies

COVID-19-induced non-cell-autonomous anosmia

Study investigates antibody-mediated response against different SARS-CoV-2 variants

Decoy ACE2 nanoparticles block the entry of SARS-CoV-2 into cells

COVID-19 severity has a stronger influence on prevention practices, study shows

UCLouvain discovery could counter SARS-CoV-2 virus independently of the mutations

Researchers warn against national strategies for a "new normal" of life with COVID-19

Narcissism affects an individual's willingness to comply with COVID-19 mitigations

Postnatal gene therapy may be able to prevent or reverse deadly effects of Pitt-Hopkins syndrome

Exploring simultaneous and sequential COVID-19 vaccine candidate

A new way of characterising biomolecules eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in